Menu

sirolimus的价格多少?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Sirolimus is an immunosuppressant developed by Pfizer of the United States. It has strong anti-rejection activity and the ability to prolong graft survival. In September 1999, the drug was approved by the US FDA for marketing. It is mainly used to prevent and treat rejection of kidney, liver and other transplants. It is especially suitable for patients with complicated renal function, tremor and hypertension. The drug has low oral bioavailability, large inter-individual pharmacokinetic (PK) differences, and is a substrate of CYP3A and P glycoprotein (PgP), which can cause drug-drug interactions with a variety of drugs. In addition, the literature reports that the most common adverse reaction of this drug is the increase in total cholesterol (TC) and triacylglycerol (TG). These adverse reactions can be effectively alleviated after intervention.

So, what is the price of sirolimus, which has such reliable safety and efficacy?

Due to the different specifications of sirolimus, there will be certain differences in the final selling price. According to the official display of the China Medical Information Query Platform, the reference price of this drug is 143.00$~2739.00$. Normally, patients can buy a box of the small-sized medicines they need for about $500. At present, sirolimus has been included in the medical insurance catalog and is a Class B drug in the medical insurance. This means that when patients purchase the drug in China, they can rely on medical insurance to reimburse part of the cost, thereby also achieving the purpose of reducing out-of-pocket expenses and reducing their own financial burden. Due to the influence of regional medical insurance policies and other factors, there will be certain differences in the final reimbursement ratio of this drug. Specific patients can consult the relevant departments.

In order to ensure that the efficacy of sirolimus can be fully exerted, patients must strictly follow the doctor's instructions or instructions during actual use, and receive timely and effective treatment when adverse reactions occur.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。